Literature DB >> 11277333

P53 overexpression in normal oral mucosa of heavy smokers.

N Ayan1, I Ayan, C Alatli, S D Guler, C Dalkilic, F Cinar, O Dogan.   

Abstract

The observation that p53 alterations are early events in the tumorigenesis of head and neck cancer and the association with cigarette smoking have prompted us to search for p53 overexpression in the oral mucosa of heavy smokers who have no overt precancerous or cancerous lesions. Formalin-fixed paraffin embedded tissue sections, obtained from oral mucosa of 30 otherwise healthy heavy smokers, were evaluated for tobacco related changes, and immunostained with a mouse monoclonal antibody p53-DO7 for p53 immunoreactivity. Histopathological evaluation revealed hyperplastic changes in twenty eight samples (93%), eight of which also demonstrated dysplastic changes. Positive immunoreaction for p53 was detected in six (20%) of the tissue samples. The study provided significant information about the frequency of hyperplasia, dysplasia, and p53 overexpression in individuals who were heavy smokers. It is suggested, also, that chemoprevention might have some impact in this particular group of individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11277333

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  3 in total

Review 1.  The field of tissue injury in the lung and airway.

Authors:  Katrina Steiling; John Ryan; Jerome S Brody; Avrum Spira
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

2.  Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers.

Authors:  Kala Jessie; Wei Wei Pang; Zubaidah Haji; Abdul Rahim; Onn Haji Hashim
Journal:  Int J Mol Sci       Date:  2010-11-09       Impact factor: 5.923

3.  p53 Overexpression in Oral Mucosa in Relation to Shisha Smoking in Syria and Lebanon

Authors:  Khaled Zaid; Elie Azar-Maalouf; Charif Barakat; Mansour Chantiri
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.